Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,308,000 | 4,089,003 | 1,282,078 | 1,478,051 | 1,204,900 |
| Marketable Securities | 2,120,500 | 1,753,499 | 1,086,595 | 673,946 | 640,500 |
| Receivables | 1,227,000 | 1,327,780 | 1,310,821 | 1,389,995 | 1,292,400 |
| Inventories | 893,400 | 918,921 | 865,738 | 825,349 | 804,000 |
| Other current assets | 1,151,400 | 1,181,670 | 1,073,753 | 891,555 | 593,200 |
| TOTAL | $6,700,300 | $9,270,873 | $5,618,985 | $5,258,896 | $4,535,000 |
| Non-Current Assets | |||||
| PPE Net | 2,187,600 | 2,027,821 | 1,837,670 | 1,739,628 | 1,765,700 |
| Investments And Advances | 3,868,000 | 2,839,575 | 2,853,384 | 2,017,955 | 2,225,300 |
| Intangibles | 6,748,900 | 6,590,099 | 6,449,132 | 6,202,975 | 5,788,700 |
| Other Non-Current Assets | 0 | 5 | 4 | 1 | 0 |
| TOTAL | $12,804,500 | $11,457,500 | $11,140,190 | $9,960,559 | $9,779,700 |
| Total Assets | $19,504,800 | $20,728,370 | $16,759,170 | $15,219,450 | $14,314,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 267,400 | 251,228 | 282,702 | 236,128 | 229,200 |
| Accrued Expenses | 2,096,800 | 1,918,897 | 1,812,099 | 1,384,774 | 1,817,700 |
| TOTAL | $2,577,700 | $2,633,968 | $2,555,832 | $1,946,231 | $2,218,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,521,500 | 6,529,275 | 576,207 | 580,672 | 580,300 |
| aiOther Non-Current Liabilities | 908,600 | 807,521 | 918,231 | 894,929 | 650,960 |
| TOTAL | $7,552,200 | $7,527,457 | $1,630,341 | $1,603,765 | $1,282,600 |
| Total Liabilities | $10,129,900 | $10,161,420 | $4,186,173 | $3,549,996 | $3,500,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 218,673 | 222,903 | 235,169 | 235,230 | 234,615 |
| Common Shares | 100 | 124 | 129 | 129 | 100 |
| Retained earnings | 12,208,400 | 11,999,360 | 11,033,740 | 10,106,460 | 9,283,900 |
| Other shareholders' equity | -221,600 | -162,917 | -100,312 | -67,555 | -54,200 |
| TOTAL | $9,374,900 | $10,566,940 | $12,573,000 | $11,669,460 | $10,814,000 |
| Total Liabilities And Equity | $19,504,800 | $20,728,360 | $16,759,173 | $15,219,456 | $14,314,700 |